SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rohan C Siriwardana, Maduni A Niriella, Anuradha S Dassanayake, Chandika Liyanage, Bhagya Gunathilaka, Subani Jayathunge, Hithanadura J de Silva, Clinical characteristics and outcome of hepatocellular carcinoma in alcohol related and cryptogenic cirrhosis: a prospective study, Hepatobiliary & Pancreatic Diseases International, 2015, 14, 4, 401

    CrossRef

  2. 2
    Ioannis Anestopoulos, Georgia Persephoni Voulgaridou, Alexandros G. Georgakilas, Rodrigo Franco, Aglaia Pappa, Mihalis I. Panayiotidis, Epigenetic therapy as a novel approach in hepatocellular carcinoma, Pharmacology & Therapeutics, 2015, 145, 103

    CrossRef

  3. 3
    Sahil Mittal, Donna L. White, Fasiha Kanwal, Norman Sussman, Hashem B. El-Serag, Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatocellular Carcinoma: How Common?, Current Hepatology Reports, 2015, 14, 2, 87

    CrossRef

  4. 4
    Xiaofang Jia, Hisao Naito, Kazuya Kitamori, Husna Yetti, Tamie Nakajima, Foods and Dietary Supplements in the Prevention and Treatment of Disease in Older Adults, 2015,

    CrossRef

  5. 5
    Michele Di Martino, Luca Saba, Sandro Bosco, Massimo Rossi, Kirchin A. Miles, Rossella Di Miscio, Concetta Valentina Lombardo, Elisabetta Tamponi, Mario Piga, Carlo Catalano, Hepatocellular carcinoma (HCC) in non-cirrhotic liver: clinical, radiological and pathological findings, European Radiology, 2014, 24, 7, 1446

    CrossRef

  6. 6
    Shane A. Wells, Quantification of Hepatic Fat and Iron with Magnetic Resonance Imaging, Magnetic Resonance Imaging Clinics of North America, 2014, 22, 3, 397

    CrossRef

  7. 7
    Donna L. White, Fasiha Kanwal, Hashem B. El–Serag, Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review, Clinical Gastroenterology and Hepatology, 2012, 10, 12, 1342

    CrossRef

  8. 8
    Xiao-Yan Duan, Liang Qiao, Jian-Gao Fan, Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma, Hepatobiliary & Pancreatic Diseases International, 2012, 11, 1, 18

    CrossRef

  9. 9
    Yvonne N. Flores, Cathy M. Lang, Jorge Salmerón, Roshan Bastani, Risk Factors for Liver Disease and Associated Knowledge and Practices Among Mexican Adults in the US and Mexico, Journal of Community Health, 2012, 37, 2, 403

    CrossRef

  10. 10
    Soo Ki Kim, Hiroyuki Marusawa, Yuji Eso, Hiroki Nishikawa, Yoshihide Ueda, Ryuichi Kita, Toru Kimura, Tsutomu Chiba, Yukio Osaki, Masatoshi Kudo, Clinical Characteristics of Non-B Non-C Hepatocellular Carcinoma: A Single-Center Retrospective Study, Digestion, 2011, 84, s1, 43

    CrossRef

  11. 11
    Masatoshi Kudo, Tailor-Made Therapy for Viral Hepatitis: Recent Advances, Digestion, 2011, 84, s1, 1

    CrossRef

  12. 12
    Satsuki Kawasaki, Osamu Hasegawa, Shinobu Satoh, Kazushi Numata, Yasuo Terauchi, Sonographic assessment of fatty liver infiltration using the measurement of para- and perirenal fat thickness, Journal of Clinical Ultrasound, 2010, 38, 9
  13. 13
    Ledu Zhou, Yun Huang, Jingdong Li, Zhiming Wang, The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma, Medical Oncology, 2010, 27, 2, 255

    CrossRef

  14. 14
    Satoru Yatsuji, Etsuko Hashimoto, Maki Tobari, Makiko Taniai, Katsutoshi Tokushige, Keiko Shiratori, Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C, Journal of Gastroenterology and Hepatology, 2009, 24, 2
  15. 15
    Etsuko Hashimoto, Satoru Yatsuji, Maki Tobari, Makiko Taniai, Nobuyuki Torii, Katsutoshi Tokushige, Keiko Shiratori, Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis, Journal of Gastroenterology, 2009, 44, S19, 89

    CrossRef

  16. 16
    N. Y. Lee, H.-K. Choi, J.-H. Shim, K.-W. Kang, Z. Dong, H. S. Choi, The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation, Carcinogenesis, 2009, 30, 4, 671

    CrossRef

  17. 17
    Rajagopal N. Aravalli, Clifford J. Steer, Erik N. K. Cressman, Molecular mechanisms of hepatocellular carcinoma, Hepatology, 2008, 48, 6
  18. 18
    Yvonne N. Flores, Hal F. Yee, Mei Leng, José J. Escarce, Roshan Bastani, Jorge Salmerón, Leo S. Morales, Risk Factors for Chronic Liver Disease in Blacks, Mexican Americans, and Whites in the United States: Results From NHANES IV, 1999-2004, The American Journal of Gastroenterology, 2008, 103, 9, 2231

    CrossRef

  19. 19
    Kinuyo Hatanaka, Masatoshi Kudo, Toyokazu Fukunaga, Kazuomi Ueshima, Hobyung Chung, Yasunori Minami, Yasuhiro Sakaguchi, Satoshi Hagiwara, Akio Orino, Yukio Osaki, Clinical Characteristics of NonBNonC- HCC: Comparison with HBV and HCV Related HCC, Intervirology, 2007, 50, 1, 24

    CrossRef

  20. 20
    Riccardo Iannaccone, Francesca Piacentini, Takamichi Murakami, Valérie Paradis, Jacques Belghiti, Masatoshi Hori, Tonsok Kim, François Durand, Kenichi Wakasa, Morito Monden, Hironobu Nakamura, Roberto Passariello, Valérie Vilgrain, Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: Helical CT and MR Imaging Findings with Clinical-Pathologic Comparison1, Radiology, 2007, 243, 2, 422

    CrossRef

  21. 21
    Satoru Yatsuji, Etsuko Hashimoto, Maki Tobari, Katsutoshi Tokushige, Keiko Shiratori, Influence of age and gender in Japanese patients with non-alcoholic steatohepatitis, Hepatology Research, 2007, 37, 12
  22. 22
    Hiroaki Hashizume, Ken Sato, Hitoshi Takagi, Tomoyuki Hirokawa, Akira Kojima, Naondo Sohara, Satoru Kakizaki, Yasushi Mochida, Tatsuo Shimura, Yutaka Sunose, Susumu Ohwada, Masatomo Mori, Primary liver cancers with nonalcoholic steatohepatitis, European Journal of Gastroenterology & Hepatology, 2007, 19, 10, 827

    CrossRef

  23. 23
    Ikuko Haruta, Etsuko Hashimoto, Ayae Kabutake, Makiko Taniai, Katsutoshi Tokushige, Keiko Shiratori, Spur cell anemia associated with a cirrhotic non-alcoholic steatohepatitis patient, Hepatology Research, 2007, 37, 6
  24. 24
    Kevin L. Kraemer, The Cost-Effectiveness and Cost-Benefit of Screening and Brief Intervention for Unhealthy Alcohol Use in Medical Settings, Substance Abuse, 2007, 28, 3, 67

    CrossRef

  25. 25
    Geoffrey C. Farrell, Claire Z. Larter, Nonalcoholic fatty liver disease: From steatosis to cirrhosis, Hepatology, 2006, 43, S1
  26. 26
    TAKASHI GOTO, Nihon Naika Gakkai Zasshi, 2006, 95, 1, 39

    CrossRef

  27. 27
    Gregg C. Allen, James R. West, Wei-Jung A. Chen, David J. Earnest, Neonatal Alcohol Exposure Permanently Disrupts the Circadian Properties and Photic Entrainment of the Activity Rhythm in Adult Rats, Alcoholism: Clinical and Experimental Research, 2005, 29, 10